Concepedia
Statistics
Publications
16
Citations
495
H-Index
13
Active since
2014
Affiliations
Institut Jules Bordet(Current)
Université Libre de Bruxelles
University of Mons
VIB-KU Leuven Center for Cancer Biology
KU Leuven
Mohammad Krayem is an author at Institut Jules Bordet specializing in molecular oncology, oncology, and medicine.
Publications per year
2014–2023
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
Jana Jeschke, Évelyne Collignon, Clémence Al Wardi et al. · Nature Cancer · 2021 · 78 citations · Full text
Medicine, Molecular Biology, Oncology +14
P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition
Ahmad Najem, Mohammad Krayem, François Salès et al. · European Journal of Cancer · 2017 · 64 citations
Medicine, Cancer Biology, Oncology +17
p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib
Mohammad Krayem, Fabrice Journé, Murielle Wiedig et al. · European Journal of Cancer · 2016 · 56 citations
Life Sciences, Molecular Biology, Oncology +13
Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells
Amel Djehal, Mohammad Krayem, Ahmad Najem et al. · European Journal of Medicinal Chemistry · 2018 · 36 citations · Full text
Life Sciences, Cell Biology, Oncology +14
Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
Laura Soumoy, Corentin Schepkens, Mohammad Krayem et al. · Cancers · 2020 · 34 citations · Full text
Medicine, Biochemistry, Oncology +17
1–5 of 16